Chih-Hsin Yang - JoVE Visualize

Showing results (101-110 of 324) with videos related to

Pageof 33

Sort By:

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012

Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFRKuei-Pin Chung, Shang-Gin Wu, Jenn-Yu Wu, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2016

Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian PopulationsYen-Fu Chen, Min-Shu Hsieh, Shang-Gin Wu, et al.

Journal of Neuro-Oncology|July 3, 2013

Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomasPei-Fang Wu, Wen-Chang Huang, James Chih-Hsin Yang, et al.

Clinical Lung Cancer|January 27, 2016

First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III TrialMark Boye, Xin Wang, Vichien Srimuninnimit, et al.

JTO Clinical and Research Reports|September 30, 2021

Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in TaiwanShang-Gin Wu, Wei-Yu Liao, Kang-Yi Su, et al.

Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 16, 2024

Real-world analysis of survival outcomes in advanced EGFR-mutant NSCLC patients treated with platinum-pemetrexed after EGFR-TKI treatment failureZong-Han Yao, Wei-Yu Liao, Chin-Yao Yang, et al.

Lung Cancer (Amsterdam, Netherlands)|April 27, 2012

Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancerMyung-Ju Ahn, James Chih-Hsin Yang, Jun Liang, et al.

JTO Clinical and Research Reports|September 30, 2021

Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC TrialJames Chih-Hsin Yang, Tony S K Mok, Shun Lu, et al.

Oncology|January 25, 2012

Survival of patients with small cell lung carcinoma in TaiwanYu-Hsuan Kuo, Zhong-Zhe Lin, Yen-Yun Yang, et al.

Anticancer Research|March 14, 2007

A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancerChia-Chi Lin, Ann-Lii Cheng, Chih-Hung Hsu, et al.

Pageof 33

Showing results (101-110 of 324) with videos related to

Sort By:

Pageof 33

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012

Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFRKuei-Pin Chung, Shang-Gin Wu, Jenn-Yu Wu, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2016

Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian PopulationsYen-Fu Chen, Min-Shu Hsieh, Shang-Gin Wu, et al.

Journal of Neuro-Oncology|July 3, 2013

Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomasPei-Fang Wu, Wen-Chang Huang, James Chih-Hsin Yang, et al.

Clinical Lung Cancer|January 27, 2016

First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III TrialMark Boye, Xin Wang, Vichien Srimuninnimit, et al.

JTO Clinical and Research Reports|September 30, 2021

Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in TaiwanShang-Gin Wu, Wei-Yu Liao, Kang-Yi Su, et al.

Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 16, 2024

Real-world analysis of survival outcomes in advanced EGFR-mutant NSCLC patients treated with platinum-pemetrexed after EGFR-TKI treatment failureZong-Han Yao, Wei-Yu Liao, Chin-Yao Yang, et al.

Lung Cancer (Amsterdam, Netherlands)|April 27, 2012

Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancerMyung-Ju Ahn, James Chih-Hsin Yang, Jun Liang, et al.

JTO Clinical and Research Reports|September 30, 2021

Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC TrialJames Chih-Hsin Yang, Tony S K Mok, Shun Lu, et al.

Oncology|January 25, 2012

Survival of patients with small cell lung carcinoma in TaiwanYu-Hsuan Kuo, Zhong-Zhe Lin, Yen-Yun Yang, et al.

Anticancer Research|March 14, 2007

A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancerChia-Chi Lin, Ann-Lii Cheng, Chih-Hung Hsu, et al.

Pageof 33